02Jul 2022
C‐peptide determination in the diagnosis of type of diabetes and its management: A clinical perspective

C‐peptide determination in the diagnosis of type of diabetes and its management: A clinical perspective

Impaired beta‐cell function is a recognized cornerstone of diabetes pathophysiology. Estimates of insulin secretory capacity are useful to inform clinical practice, helping to classify types of diabetes, complication risk stratification and to guide treatment decisions. This review summarizes the current evidence base about the potential value of C‐peptide in the management of the two most prevalent forms of diabetes (type 2 diabetes and autoimmune diabetes) to address how its measurement may assist daily clinical practice and to highlight current limitations and areas of uncertainties to be covered by future research.

  • #endo-diabetology

Like

Save

Share